Hyperphagia of hyperthyroidism: is neuropeptide Y involved?
The possible role of neuropeptide Y (NPY) was studied in rats with hypermetabolism and hyperphagia induced by thyroxine (50-100-200 microg/day s.c. for 3-4 weeks). Both metabolic rate and body temperature increased quickly with thyroxine treatment, while hyperphagia started to develop only after 2 weeks of treatment. The weight gain rate progressively decreased or stopped. The NPY-induced hyperphagia was not altered significantly during thyroxine treatment (in severe thyrotoxicosis it was rather suppressed); the fasting-induced hyperphagia was smaller than in controls following 1 week of treatment, and it became enhanced only after 3 weeks, when the deficit in body weight indicated a certain level of starvation already prior to the food deprivation. The NPY-antagonist D-Tyr27,36,D-Thr32-NPY27,36 suppressed this fasting-induced hyperphagia, suggesting that endogenous NPY is involved in this late phase. In conclusion, hyperthyroidism per se does not increase the NPY activity, instead the quickly developing hyperthermia may inhibit the NPY actions; NPY may, however, be activated by a concurrent hypermetabolism-induced starvation.
Pétervári
Erika
E
Department of Pathophysiology, Faculty of Medicine, University of Pécs, 12 Szigeti út, H-7624 Pécs, Hungary.
Balaskó
Márta
M
Jech-Mihálffy
Andrea
A
Székely
Miklós
M
D000818:Animals; D001831:Body Temperature; D001835:Body Weight; D004435:Eating; D004734:Energy Metabolism; D005260:Female; D005508:Food Deprivation; D006963:Hyperphagia / Q000378:metabolism*; D006980:Hyperthyroidism / Q000378:metabolism*; D008297:Male; D009478:Neuropeptide Y / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D013974:Thyroxine / Q000008:administration & dosage / Q000378:metabolism
D009478:Neuropeptide Y; D013974:Thyroxine